Bromma, Sweden

Jacques Näsström


 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Jacques Näsström

Introduction

Jacques Näsström is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of medical treatments, particularly in the area of liver health. With a total of five patents to his name, Näsström's work focuses on innovative methods and formulations for treating acute liver failure and other hepatotoxic conditions.

Latest Patents

Näsström's latest patents include groundbreaking methods for treating and protecting against acute liver failure. One of his notable inventions employs a combination of N-acetylcysteine and a manganese complex. This complex can consist of a calcium manganese mixed metal complex or a mixture of manganese compounds, aimed at enhancing liver function and reducing toxicity. Another patent outlines methods and formulations that utilize agents to replenish functional glutathione in individuals, further supporting liver health.

Career Highlights

Throughout his career, Jacques Näsström has worked with prominent companies such as Pledpharma AB and Egetis Therapeutics AB. His experience in these organizations has allowed him to develop and refine his innovative approaches to liver treatment. Näsström's dedication to research and development has positioned him as a key figure in the medical field.

Collaborations

Some of Näsström's notable coworkers include Sven Jacobsson and Jan-Olof G Karlsson. Their collaboration has contributed to the advancement of research in hepatotoxicity and liver treatment methodologies.

Conclusion

Jacques Näsström's contributions to medical innovation, particularly in liver health, highlight his role as a significant inventor. His patents reflect a commitment to improving treatment options for acute liver failure and other related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…